Never Miss a Potential Recovery Again

Sign up for Class
Action Alerts

Each year, class action lawsuits generate billions of dollars in settlement funds, but many shareholders fail to file a claim. Stay in the know regarding class action lawsuits by signing up for alerts.

There is no cost or obligation for you to submit. No spam will be sent to your email.

$349,875,000 in Total Settlement Funds Available. See if you qualify!Find Out More

We Give Shareholders A Voice.

The market fluctuates, but we don’t. We give you straight answers from real attorneys who have spent decades helping shareholders protect their investments and recover their losses.

Settlements

$47.5 Million

QuantumScape Corporation

$24.6 Million

Loma Negra Industrial Argentina Sociedad Argentina

$14 Million

Corcept Therapeutics Incorporated

$9.5 Million

Babcock & Wilcox Enterprises, Inc.

$40 Million

U.S. Steel

$7 Million

Aqua Metals, Inc.

$7.025 Million

WideOpenWest, Inc.

$8.25 Million

Helios and Matheson Analytics Inc.

$13.85 Million

Illumina, Inc.

$14.5 Million

Avon Products Inc.

I think you’ve done a superb job and I really appreciate the way this case was handled.

The Honorable Ronald B. Rubin in Teoh v. Ferrantino, C.A. No. 356627 (Cir. Ct. for Montgomery Cnty., MD 2012)

…a model for how [the] great legal profession should conduct itself.

Justice Timothy S. Driscoll in Grossman v. State Bancorp, Inc., Index No. 600469/2011 (N.Y. Sup. Ct. Nassau Cnty. Nov. 29, 2011)

I find the firm to be well-qualified to serve as Lead Counsel.

The Honorable Andrew L. Carter, Jr. In Snyder v. Baozun Inc., No. 1:19-CV-11290 (S.D.N.Y. Sept. 8, 2020)

In appointing the Firm Lead Counsel, the Honorable Analisa Torres noted our “extensive experience” in securities litigation.

White Pine Invs. v. CVR Ref., LP, No. 20 CIV. 2863 (S.D.N.Y. Jan. 5, 2021)

Class Counsel have demonstrated that they are skilled in this area of the law and therefore adequate to represent the Settlement Class as well.

Furthermore, with the increasing importance of compliance and risk management, kyc for law firms has become an essential component of legal services.

The Honorable Barry Ted Moskowitz in In re Regulus Therapeutics Inc. Sec. Litig., No. 3:17-CV-182-BTM-RBB (S.D. Cal. Oct. 30, 2020)

Who We Are

We combine specialized securities expertise with an innovative approach to litigation and an enduring commitment to our clients. We represent individuals, institutions, and asset managers in some of the largest, most complex securities cases in the country and never shy away from an uphill battle.

Online casinos that accept a minimum deposit of $10 are a great option for players who want to try out their luck without risking too much money. These 10 dollar deposit casinos offer a variety of games, including slots, table games, and live dealer games, as well as various payment options to make depositing and withdrawing funds easy.

Nos últimos anos, os casinos online tornaram-se extremamente populares, e um número crescente de jogadores está a optar por fazê-lo a partir do conforto das suas próprias casas. Um dos métodos de pagamento mais bem aceites pelos casinos online é o PayPal, uma carteira digital que permite aos utilizadores depositar e receber dinheiro de forma simples e segura. Os casinos PayPal são estabelecimentos de jogo online que aceitam PayPal como forma de pagamento.
A popularidade do PayPal como método de pagamento de casino online pode ser atribuída tanto à sua usabilidade como às suas características de segurança. Quando utiliza o PayPal para fazer um depósito ou levantamento num casino, não precisa de dar ao casino acesso aos seus dados financeiros pessoais. Apenas precisa do seu endereço de e-mail e palavra-passe PayPal para completar a transacção. Isto reduz significativamente a probabilidade de fraude e roubo de identidade. Além disso, as transacções PayPal são processadas rapidamente, permitindo-lhe começar quase imediatamente a jogar os jogos de casino que escolheu.

Mi is a status company working with securities and innovative approaches with online casino gamblers. We provide you with an open door to our offices where online casino players can view a win palace review. Our company, together with online casinos, works in more than 40 courts throughout the country and is considered the best company.

O facto de o PayPal ser amplamente reconhecido é um benefício adicional da sua utilização num casino online pagamento Paypal. Porque o PayPal é um método de pagamento fiável e bem respeitado, vários casinos online decidiram incluí-lo na sua lista de métodos de pagamento aprovados. Tem agora opções adicionais para jogar porque uma variedade de casinos em linha aceita PayPal para depósitos e levantamentos.
Um casino PayPal é um casino online que aceita PayPal como uma forma de pagamento. Ao optar por financiar as suas contas em casinos online com PayPal, os jogadores têm uma opção segura, segura e útil. Dada a sua conveniência, características de segurança, e aceitação geral, faz sentido que o PayPal se tenha tornado um dos métodos de pagamento mais frequentemente utilizados para casinos online. Se procura um método de pagamento fiável e de confiança para as suas actividades de jogo online, pense em utilizar PayPal num casino que aceite PayPal.

In the fast-paced world of online casinos, one of the most critical elements to ensuring that their business is legally compliant is working with the best lawyers. The legal landscape around online gambling is complex and constantly evolving, making it essential for online casinos to have legal experts on hand to help navigate this tricky terrain. In this article, we will explore how online casinos cooperate with the best lawyers and why this is essential to their success. Firstly, working with the best lawyers can help online casinos https://casinosworld.ca/best-payout-online-casinos/ ensure that they are operating within the confines of the law. Online gambling regulations can vary significantly from jurisdiction to jurisdiction, and it can be challenging for online casinos to stay on top of the latest changes. By working with experienced lawyers who specialize in gambling law, online casinos can be confident that they are always up to date with the latest legal developments and that their business is fully compliant.

Ice hockey is one of the most exciting and dynamic sports in the world, and it’s no surprise that many people enjoy betting on it. However, one group of professionals that has taken a particular interest in hockey betting is lawyers and attorneys. In this article, we will explore why hockey betting is popular among lawyers and attorneys and what they enjoy about this unique form of gambling. One reason that lawyers and attorneys enjoy hockey betting is that it requires a deep understanding of the game and its rules. As legal professionals, they are trained to analyze complex information and make informed decisions based on that information. This analytical approach is well-suited to sports betting, where successful bettors must understand the intricacies of the game and make informed decisions based on those details. Hockey betting provides a unique challenge that many lawyers and attorneys find appealing. Another reason that hockey betting https://thewincolumn.ca/2023/02/11/sports-betting-101-how-to-bet-on-hockey/ is popular among lawyers and attorneys is that it allows them to stay up to date with the latest legal developments in the sports world. As legal professionals, they are always looking for new opportunities to expand their knowledge and expertise. By betting on hockey, they can stay up to date with the latest developments in the sport, including any changes to the rules or regulations that may affect betting odds.

1
1
1
1
1
1

We're here for you

Find an Attorney

Required Field

Coin Image

Don't hesitate

Find a Case

Upcoming Deadlines

Investors interested in taking an active role in litigation have a limited time to petition the court for appointment as lead plaintiff. If you are interested in acting as a lead plaintiff, submit your transactions before the deadline, and our analysts will calculate your losses. Don't wait till the last minute- discuss your options today.
View All Deadlines

5

Days Left

DV

DoubleVerify Holdings, Inc.

Deadline

July 21 2025

Class Period

11/10/23 - 2/27/25

Allegations

(a) DoubleVerify’s customers were shifting their ad spending from open exchanges to closed platforms, where the Company’s technological capabilities were limited and competed directly with native tools provided by platforms like Meta Platforms and Amazon; (b) DoubleVerify’s ability to monetize on its Activation Services was limited because the development of its technology for closed platforms was significantly more expensive and time-consuming than disclosed to investors; (c) DoubleVerify’s Activation Services in connection with certain closed platforms would take several years to monetize; (d) DoubleVerify’s competitors were better positioned to incorporate AI into their offerings on closed platforms, which impaired DoubleVerify’s ability to compete effectively and adversely impacted the Company’s profits; (e) DoubleVerify systematically overbilled its customers for ad impressions served to declared bots operating out of known data center server farms; (f) DoubleVerify’s risk disclosures were materially false and misleading because they characterized adverse facts that had already materialized as mere possibilities; and (g) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially false and/or misleading or lacked a reasonable basis.

Class Period

11/10/23 - 2/27/25

Deadline

July 21 2025

Learn More

6

Days Left

RCAT

Red Cat Holdings, Inc.

Deadline

July 22 2025

Class Period

3/18/22 - 1/15/25

Allegations

(i) the Salt Lake City Facility’s production capacity, and defendants’ progress in developing the same, was overstated; (ii) the overall value of the U.S. Army’s Short Range Reconnaissance Program of Record Tranche 2 contract was overstated; and (iii) as a result, defendants’ public statements were materially false and misleading at all relevant times.

Class Period

3/18/22 - 1/15/25

Deadline

July 22 2025

Learn More

6

Days Left

OGN

Organon & Co.

Deadline

July 22 2025

Class Period

10/31/24 - 4/30/25

Allegations

According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Organon’s priorities, particularly, related to capital allocation through quarterly dividends. Notably, defendants concealed the high priority of Organon’s debt reduction strategy following the Company’s acquisition of Dermavant, resulting in a 70% decrease for the regular quarterly dividend. Following this news, the price of Organon’s common stock declined dramatically. From a closing market price of $12.93 per share on April 30, 2025, Organon’s stock price fell to $9.45 per share on May 1, 2025, a decline of more than 27% in the span of just a single day.

Class Period

10/31/24 - 4/30/25

Deadline

July 22 2025

Learn More

16

Days Left

FTRE

Fortrea Holdings Inc.

Deadline

August 1 2025

Class Period

7/3/23 - 2/28/25

Allegations

(i) Fortrea overestimated the amount of revenue the long-term projects in its portfolio, the Pre-Spin Projects, were likely to contribute to the Company’s 2025 earnings; (ii) Fortrea overstated the cost savings it would likely achieve by exiting the transition services agreements; (iii) as a result, the Company’s previously announced EBITDA targets for 2025 were inflated; (iv) accordingly, the viability of the Company’s post-spin-off business model, as well as its business and/or financial prospects, were overstated; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Class Period

7/3/23 - 2/28/25

Deadline

August 1 2025

Learn More

19

Days Left

RBGLY

Reckitt Benckiser Group plc

Deadline

August 4 2025

Class Period

1/13/21 - 7/28/24

Allegations

(1) preterm infants were at an increased risk of developing NEC by consuming Reckitt’s cow’s milk-based formula, Enfamil; (2) of the attendant impact on Reckitt’s sales of Enfamil and Reckitt’s exposure to legal claims; and (3) as a result of the above, defendants’ positive statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Class Period

1/13/21 - 7/28/24

Deadline

August 4 2025

Learn More

23

Days Left

PEPG

PepGen Inc.

Deadline

August 8 2025

Class Period

3/7/24 - 3/3/25

Allegations

(i) the Company’s lead product candidate, PGN-EDO51, was less effective and safe than defendants had led investors to believe; (ii) phase two, CONNECT2 study was dangerous or otherwise deficient for purposes of U.S. Food and Drug Administration (“FDA”) approval; (iii) as a result of all the foregoing, PepGen was likely to halt the CONNECT2 study, and PGN-EDO51’s clinical, regulatory, and commercial prospects were overstated; and (iv) as a result, defendants’ public statements were materially false and misleading at all relevant times.

Class Period

3/7/24 - 3/3/25

Deadline

August 8 2025

Learn More

23

Days Left

VSTS

Vestis Corporation

Deadline

August 8 2025

Class Period

5/2/24 - 5/6/25

Allegations

According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Vestis’ ability to grow its business; notably that Vestis would be unable to execute on planned strategic initiatives to drive purported improvements to the customer experience and its onboarding efforts in order to drive new customer growth, increased customer retention, and increased revenue from existing customers. On May 7, 2025, Vestis announced its financial results for the second quarter of fiscal 2025, withdrew its revenue and growth guidance for the full fiscal year 2025, and provided guidance for the third quarter of fiscal 2025 that fell significantly below market expectations. The Company attributed its poor results partially to “lost business in excess of new business,” but primarily on “lower adds over stops, which is how we describe volume changes with our existing customers.” The Company attributed its decision to pull full-year guidance and provide disappointing third quarter targets to the “increasingly uncertain macro environment.” Following this news, the price of Vestis’ common stock declined dramatically. From a closing market price of $8.71 per share on May 6, 2025, Vestis’ stock price fell to $5.44 per share on May 7, 2025, a decline of about 37.54% in the span of just a single day.

Class Period

5/2/24 - 5/6/25

Deadline

August 8 2025

Learn More

26

Days Left

RCKT

Rocket Pharmaceuticals, Inc.

Deadline

August 11 2025

Class Period

2/27/25 - 5/26/25

Allegations

According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of RP-A501’s safety and clinical trial protocol; notably, that Rocket knew Serious Adverse Events (SAEs), including death of participants enrolled in the study, were a risk. In particular, Rocket amended the trial’s protocol to introduce a novel immunomodulatory agent to the pretreatment regimen without providing this critical update to shareholders. Such statements absent these material facts caused Plaintiff and other shareholders to purchase Rocket’s securities at artificially inflated prices. On May 27, 2025, Rocket announced that the FDA placed a clinical hold on the RP-A501 Phase 2 pivotal study after at least one patient suffered a Serious Adverse Event (SAE), ultimately, death, while enrolled in the study following a substantive amendment to the protocol that the Company failed to disclose to investors at the time management made the revision. In fact, Rocket stated that, while the patient was dosed in May, the decision to amend the protocol was made “several months” earlier. Despite this, Rocket made no attempt to alert investors or the public to the change until after the SAE occurred. Following this news, the price of Rocket’s common stock declined dramatically. From a closing market price of $6.27 per share on May 23, 2025, Rocket’s stock price fell to $2.33 per share on May 27, 2025, a decline of about 37% in the span of just a single trading day.

Class Period

2/27/25 - 5/26/25

Deadline

August 11 2025

Learn More

27

Days Left

DDD

3D Systems Corporation

Deadline

August 12 2025

Class Period

8/13/24 - 5/12/25

Allegations

(i) 3D Systems had understated the impact of weakened customer spending on the Company’s business, while overstating its resilience in challenging industry conditions; (ii) in addition, the updated milestone criteria in the partnership with United Therapeutics Corporation would negatively impact the Company’s regenerative medicine program revenue; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Class Period

8/13/24 - 5/12/25

Deadline

August 12 2025

Learn More

33

Days Left

RDDT

Reddit, Inc.

Deadline

August 18 2025

Class Period

10/29/24 - 5/20/25

Allegations

(i) changes in Google Search’s algorithm and features like AI Overview were causing users to stop their query on Google Search; (ii) these algorithm changes were materially different than prior instances of reduced traffic to the Reddit website; (iii) defendants were aware that the increase in the query term “Reddit” on search engines was because users were getting the sought after answer from Google Search without having to go to Reddit, and not because they intended to visit Reddit; (iv) this zero-click search reality was dramatically reducing traffic to Reddit in a manner the Company was unable to overcome in the short term; (v) defendants, therefore, lacked a reasonable basis for their outlook on user rates and advertising revenues; and (vi) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Class Period

10/29/24 - 5/20/25

Deadline

August 18 2025

Learn More

34

Days Left

AAPL

Apple Inc.

Deadline

August 19 2025

Class Period

6/10/24 - 6/9/25

Allegations

(i) Apple misstated the time it would take to integrate the advanced AI-based Siri features into its devices; (ii) accordingly, it was highly unlikely that these features would be available for the iPhone 16; (iii) the lack of such advanced AI-based features would hurt iPhone 16 sales; (iv) as a result, Apple’s business and/or financial prospects were overstated; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Class Period

6/10/24 - 6/9/25

Deadline

August 19 2025

Learn More

40

Days Left

SRPT

Sarepta Therapeutics, Inc.

Deadline

August 25 2025

Class Period

6/22/23 - 6/24/25

Allegations

(i) ELEVIDYS, a prescription gene therapy for Duchenne, posed significant safety risks to patients; (ii) ELEVIDYS trial regimes and protocols failed to detect severe side effects; (iii) the severity of adverse events from ELEVIDYS treatment would cause the Company to halt recruitment and dosing in ELEVIDYS trials, attract regulatory scrutiny, and create greater risk around the therapy’s present and expanded approvals; and (iv) as a result of the foregoing, defendants materially misled with, and/or lacked a reasonable basis for, their positive statements.

Class Period

6/22/23 - 6/24/25

Deadline

August 25 2025

Learn More

40

Days Left

HIMS

Hims & Hers Health, Inc.

Deadline

August 25 2025

Class Period

4/29/25 - 6/23/25

Allegations

(1) Hims was engaged in the “deceptive promotion and selling of illegitimate, knockoff versions of Wegovy® that put patient safety at risk;” (2) as a result, there was a substantial risk that the Company’s collaboration with Novo Nordisk would be terminated; and (3) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Class Period

4/29/25 - 6/23/25

Deadline

August 25 2025

Learn More

44

Days Left

WOOF

Petco Health and Wellness Company, Inc.

Deadline

August 29 2025

Class Period

1/14/21 - 6/5/25

Allegations

(i) Petco’s pandemic-related tailwinds were unsustainable, as was its business model of selling primarily premium and/or high-grade pet food; (ii) accordingly, the strength of Petco’s differentiated product strategy was overstated; (iii) defendants downplayed the true scope and severity of the foregoing issues, the magnitude of changes needed to rectify those issues, and the likely negative impacts of their mitigation strategy on Petco’s comparable sales metric; (iv) accordingly, defendants overstated Petco’s ability to deliver sustainable, profitable growth; and (v) as a result, defendants’ public statements were materially false and misleading at all relevant times.

Class Period

1/14/21 - 6/5/25

Deadline

August 29 2025

Learn More

51

Days Left

IRBT

iRobot Corporation

Deadline

September 5 2025

Class Period

1/29/24 - 3/11/25

Allegations

(i) iRobot overstated the extent to which the restructuring plan would help the Company maintain stability after the termination of the Amazon acquisition; (ii) as a result, it was unlikely that iRobot would be able to profitably operate as a standalone company; (iii) accordingly, there was substantial doubt about the Company’s ability to continue as a going concern; and (iv) as a result, defendants’ public statements were materially false and misleading at all relevant times.

Class Period

1/29/24 - 3/11/25

Deadline

September 5 2025

Learn More

54

Days Left

CNC

Centene Corporation

Deadline

September 8 2025

Class Period

12/12/24 - 6/30/25

Allegations

According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Centene’s enrollment and morbidity rates. Investors began to question the veracity of defendants’ public statements on July 1, 2025, when Centene issued a press release withdrawing 2025 guidance. Particularly, following an analysis of the 2025 Health Insurance Marketplace, Centene’s overall market growth across 22 states, or 72% of the Company’s marketplace membership, was lower than expected. In pertinent part, the Company stated that this preliminary analysis resulted in a reduction of its previously issued guidance to approximately $1.8 billion or an adjusted diluted EPS of $2.75. Following this news, Centene’s common stock declined dramatically, from a closing market price of $56.65 per share on July 1, 2025, Centene’s stock price fell to $33.78 per share on July 2, 2025, a decline of 40.4%.

Class Period

12/12/24 - 6/30/25

Deadline

September 8 2025

Learn More

54

Days Left

XIFR

XPLR Infrastructure, LP f/k/a Nextera Energy Partners, LP

Deadline

September 8 2025

Class Period

9/27/23 - 1/27/25

Allegations

(i) XPLR was struggling to maintain its operations as a yieldco; (ii) defendants temporarily relieved this issue by entering into certain financing arrangements, described herein, while downplaying the attendant risks; (iii) XPLR could not resolve those financings before their maturity date without risking significant unitholder dilution; (iv) as a result, defendants planned to halt cash distributions to investors and instead redirect those funds to, inter alia, resolve those financings; (v) as a result of all the foregoing, XPLR’s yieldco business model and distribution growth rate was unsustainable; and (vi) as a result, defendants’ public statements were materially false and misleading at all relevant times.

Class Period

9/27/23 - 1/27/25

Deadline

September 8 2025

Learn More

356280

Days Left

AOUT

American Outdoor Brands, Inc.

Deadline

January 1 3001

Class Period

7/2/20 - 7/2/25

Allegations

American Outdoor issued a press release on June 26, 2025, reporting its financial results for its fourth quarter and full fiscal year 2025. Among other items, American Outdoor disclosed that retailers accelerated orders in the final weeks of the quarter, effectively pulling forward an estimated $8 million to $10 million in sales from the upcoming fiscal year. American Outdoor also announced its decision to suspend its fiscal 2026 guidance, citing uncertainties around tariffs. Following this news, American Outdoor's stock price fell over 13% on June 27, 2025.

Class Period

7/2/20 - 7/2/25

Deadline

January 1 3001

Learn More

View All Deadlines

News

Stay informed with the latest in settlement notices, case updates, publications, analyst reports, and more.
View All News

Learn More

RCAT Sued After Drone Claims Crash
Red Cat said it was ready to soar, telling investors it could pump out “thousands” of drones per month.  But when investors learned that was a bunch of hot air, Red Cat’s stock took a crash landing.  Now, investors are suing. In 2022, Red Cat execs told investors their Salt Lake City factor was ready...Read more

July 15, 2025

Learn More

DV Investors Sue Over Ad Fraud Fallout
DoubleVerify told investors it had cracked digital ads. But behind the buzzwords and Meta deals, it was just a bunch of zeros.  By early 2025, the stock cratered 70%.  Now, investors are suing to recover their losses. According to the lawsuit, execs hyped their Activation Services as the future of ad targeting. They said growth...Read more

July 14, 2025

Learn More

OGN Shareholders Sue Over Dividend Deception
Organon promised shareholders dividends were top priority. But after those dividends got slashed to pay down debt, shareholders dumped their Organon stock — and it was the stock price that got slashed next, dropping 27%. Now, enraged investors are fighting back with a class-action lawsuit against the Company. In late 2024, Organon executives told investors...Read more

July 14, 2025

View All News

Our World-Class Team

Levi & Korsinsky’s attorneys are admitted in over 40 state, federal, and appeal courts across the country. We have the specialized securities skills to achieve outstanding results, and our impressive variety of backgrounds means that we can go up against large companies of any kind and win. Our powerhouse attorneys have backgrounds in accounting, engineering, SEC enforcement, mathematics, regulatory analysis, international business, and prosecution, to name just a few. . .

View Attorneys